0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tianeptine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-38Y8123
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Tianeptine Market Insights Forecast to 2028
BUY CHAPTERS

Global Tianeptine Market Research Report 2025

Code: QYRE-Auto-38Y8123
Report
July 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tianeptine Market Size

The global market for Tianeptine was valued at US$ 2441 million in the year 2024 and is projected to reach a revised size of US$ 3330 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Tianeptine Market

Tianeptine Market

Tianeptine, sold under the brand names Stablon and Coaxil among others, is an atypical antidepressant which is used mainly in the treatment of major depressive disorder, although it may also be used to treat anxiety, asthma, and irritable bowel syndrome.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tianeptine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tianeptine.
The Tianeptine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tianeptine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tianeptine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tianeptine Market Report

Report Metric Details
Report Name Tianeptine Market
Accounted market size in year US$ 2441 million
Forecasted market size in 2031 US$ 3330 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Servier, Lupin Limited, PharmaS, Antibiotice, Serdia Pharmaceuticals, Alvogen, Bausch Health, Genefar B.V., Arena Pharmaceuticals, Glenmark, Novartis, Dongwha Pharm, Liconsa SA, Mylan, Adamed, Neuraxpharm Arzneimittel, Grupo Insud
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tianeptine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tianeptine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Tianeptine Market growing?

Ans: The Tianeptine Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Tianeptine Market size in 2031?

Ans: The Tianeptine Market size in 2031 will be US$ 3330 million.

Who are the main players in the Tianeptine Market report?

Ans: The main players in the Tianeptine Market are Servier, Lupin Limited, PharmaS, Antibiotice, Serdia Pharmaceuticals, Alvogen, Bausch Health, Genefar B.V., Arena Pharmaceuticals, Glenmark, Novartis, Dongwha Pharm, Liconsa SA, Mylan, Adamed, Neuraxpharm Arzneimittel, Grupo Insud

What are the Application segmentation covered in the Tianeptine Market report?

Ans: The Applications covered in the Tianeptine Market report are Depression and Anxiety, Irritable Bowel Syndrome

What are the Type segmentation covered in the Tianeptine Market report?

Ans: The Types covered in the Tianeptine Market report are Patent, Generic

Recommended Reports

Mental Health Drugs

Active Pharmaceutical Ingredients

Ophthalmic & CNS Drugs

1 Tianeptine Market Overview
1.1 Product Definition
1.2 Tianeptine by Type
1.2.1 Global Tianeptine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Patent
1.2.3 Generic
1.3 Tianeptine by Application
1.3.1 Global Tianeptine Market Value by Application (2024 VS 2031)
1.3.2 Depression and Anxiety
1.3.3 Irritable Bowel Syndrome
1.4 Global Tianeptine Market Size Estimates and Forecasts
1.4.1 Global Tianeptine Revenue 2020-2031
1.4.2 Global Tianeptine Sales 2020-2031
1.4.3 Global Tianeptine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tianeptine Market Competition by Manufacturers
2.1 Global Tianeptine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tianeptine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tianeptine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tianeptine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tianeptine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tianeptine, Product Type & Application
2.7 Global Key Manufacturers of Tianeptine, Date of Enter into This Industry
2.8 Global Tianeptine Market Competitive Situation and Trends
2.8.1 Global Tianeptine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tianeptine Players Market Share by Revenue
2.8.3 Global Tianeptine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tianeptine Market Scenario by Region
3.1 Global Tianeptine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tianeptine Sales by Region: 2020-2031
3.2.1 Global Tianeptine Sales by Region: 2020-2025
3.2.2 Global Tianeptine Sales by Region: 2026-2031
3.3 Global Tianeptine Revenue by Region: 2020-2031
3.3.1 Global Tianeptine Revenue by Region: 2020-2025
3.3.2 Global Tianeptine Revenue by Region: 2026-2031
3.4 North America Tianeptine Market Facts & Figures by Country
3.4.1 North America Tianeptine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tianeptine Sales by Country (2020-2031)
3.4.3 North America Tianeptine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tianeptine Market Facts & Figures by Country
3.5.1 Europe Tianeptine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tianeptine Sales by Country (2020-2031)
3.5.3 Europe Tianeptine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tianeptine Market Facts & Figures by Region
3.6.1 Asia Pacific Tianeptine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tianeptine Sales by Region (2020-2031)
3.6.3 Asia Pacific Tianeptine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tianeptine Market Facts & Figures by Country
3.7.1 Latin America Tianeptine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tianeptine Sales by Country (2020-2031)
3.7.3 Latin America Tianeptine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tianeptine Market Facts & Figures by Country
3.8.1 Middle East and Africa Tianeptine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tianeptine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tianeptine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tianeptine Sales by Type (2020-2031)
4.1.1 Global Tianeptine Sales by Type (2020-2025)
4.1.2 Global Tianeptine Sales by Type (2026-2031)
4.1.3 Global Tianeptine Sales Market Share by Type (2020-2031)
4.2 Global Tianeptine Revenue by Type (2020-2031)
4.2.1 Global Tianeptine Revenue by Type (2020-2025)
4.2.2 Global Tianeptine Revenue by Type (2026-2031)
4.2.3 Global Tianeptine Revenue Market Share by Type (2020-2031)
4.3 Global Tianeptine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tianeptine Sales by Application (2020-2031)
5.1.1 Global Tianeptine Sales by Application (2020-2025)
5.1.2 Global Tianeptine Sales by Application (2026-2031)
5.1.3 Global Tianeptine Sales Market Share by Application (2020-2031)
5.2 Global Tianeptine Revenue by Application (2020-2031)
5.2.1 Global Tianeptine Revenue by Application (2020-2025)
5.2.2 Global Tianeptine Revenue by Application (2026-2031)
5.2.3 Global Tianeptine Revenue Market Share by Application (2020-2031)
5.3 Global Tianeptine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Servier
6.1.1 Servier Company Information
6.1.2 Servier Description and Business Overview
6.1.3 Servier Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Servier Tianeptine Product Portfolio
6.1.5 Servier Recent Developments/Updates
6.2 Lupin Limited
6.2.1 Lupin Limited Company Information
6.2.2 Lupin Limited Description and Business Overview
6.2.3 Lupin Limited Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lupin Limited Tianeptine Product Portfolio
6.2.5 Lupin Limited Recent Developments/Updates
6.3 PharmaS
6.3.1 PharmaS Company Information
6.3.2 PharmaS Description and Business Overview
6.3.3 PharmaS Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 PharmaS Tianeptine Product Portfolio
6.3.5 PharmaS Recent Developments/Updates
6.4 Antibiotice
6.4.1 Antibiotice Company Information
6.4.2 Antibiotice Description and Business Overview
6.4.3 Antibiotice Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Antibiotice Tianeptine Product Portfolio
6.4.5 Antibiotice Recent Developments/Updates
6.5 Serdia Pharmaceuticals
6.5.1 Serdia Pharmaceuticals Company Information
6.5.2 Serdia Pharmaceuticals Description and Business Overview
6.5.3 Serdia Pharmaceuticals Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Serdia Pharmaceuticals Tianeptine Product Portfolio
6.5.5 Serdia Pharmaceuticals Recent Developments/Updates
6.6 Alvogen
6.6.1 Alvogen Company Information
6.6.2 Alvogen Description and Business Overview
6.6.3 Alvogen Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Alvogen Tianeptine Product Portfolio
6.6.5 Alvogen Recent Developments/Updates
6.7 Bausch Health
6.7.1 Bausch Health Company Information
6.7.2 Bausch Health Description and Business Overview
6.7.3 Bausch Health Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bausch Health Tianeptine Product Portfolio
6.7.5 Bausch Health Recent Developments/Updates
6.8 Genefar B.V.
6.8.1 Genefar B.V. Company Information
6.8.2 Genefar B.V. Description and Business Overview
6.8.3 Genefar B.V. Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Genefar B.V. Tianeptine Product Portfolio
6.8.5 Genefar B.V. Recent Developments/Updates
6.9 Arena Pharmaceuticals
6.9.1 Arena Pharmaceuticals Company Information
6.9.2 Arena Pharmaceuticals Description and Business Overview
6.9.3 Arena Pharmaceuticals Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Arena Pharmaceuticals Tianeptine Product Portfolio
6.9.5 Arena Pharmaceuticals Recent Developments/Updates
6.10 Glenmark
6.10.1 Glenmark Company Information
6.10.2 Glenmark Description and Business Overview
6.10.3 Glenmark Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Glenmark Tianeptine Product Portfolio
6.10.5 Glenmark Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Company Information
6.11.2 Novartis Description and Business Overview
6.11.3 Novartis Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novartis Tianeptine Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 Dongwha Pharm
6.12.1 Dongwha Pharm Company Information
6.12.2 Dongwha Pharm Description and Business Overview
6.12.3 Dongwha Pharm Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Dongwha Pharm Tianeptine Product Portfolio
6.12.5 Dongwha Pharm Recent Developments/Updates
6.13 Liconsa SA
6.13.1 Liconsa SA Company Information
6.13.2 Liconsa SA Description and Business Overview
6.13.3 Liconsa SA Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Liconsa SA Tianeptine Product Portfolio
6.13.5 Liconsa SA Recent Developments/Updates
6.14 Mylan
6.14.1 Mylan Company Information
6.14.2 Mylan Description and Business Overview
6.14.3 Mylan Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Mylan Tianeptine Product Portfolio
6.14.5 Mylan Recent Developments/Updates
6.15 Adamed
6.15.1 Adamed Company Information
6.15.2 Adamed Description and Business Overview
6.15.3 Adamed Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Adamed Tianeptine Product Portfolio
6.15.5 Adamed Recent Developments/Updates
6.16 Neuraxpharm Arzneimittel
6.16.1 Neuraxpharm Arzneimittel Company Information
6.16.2 Neuraxpharm Arzneimittel Description and Business Overview
6.16.3 Neuraxpharm Arzneimittel Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Neuraxpharm Arzneimittel Tianeptine Product Portfolio
6.16.5 Neuraxpharm Arzneimittel Recent Developments/Updates
6.17 Grupo Insud
6.17.1 Grupo Insud Company Information
6.17.2 Grupo Insud Description and Business Overview
6.17.3 Grupo Insud Tianeptine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Grupo Insud Tianeptine Product Portfolio
6.17.5 Grupo Insud Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tianeptine Industry Chain Analysis
7.2 Tianeptine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tianeptine Production Mode & Process Analysis
7.4 Tianeptine Sales and Marketing
7.4.1 Tianeptine Sales Channels
7.4.2 Tianeptine Distributors
7.5 Tianeptine Customer Analysis
8 Tianeptine Market Dynamics
8.1 Tianeptine Industry Trends
8.2 Tianeptine Market Drivers
8.3 Tianeptine Market Challenges
8.4 Tianeptine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Tianeptine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Tianeptine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Tianeptine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Tianeptine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Tianeptine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Tianeptine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Tianeptine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Tianeptine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Tianeptine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tianeptine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tianeptine, Product Type & Application
 Table 12. Global Key Manufacturers of Tianeptine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tianeptine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tianeptine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tianeptine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Tianeptine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Tianeptine Sales Market Share by Region (2020-2025)
 Table 19. Global Tianeptine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Tianeptine Sales Market Share by Region (2026-2031)
 Table 21. Global Tianeptine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Tianeptine Revenue Market Share by Region (2020-2025)
 Table 23. Global Tianeptine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Tianeptine Revenue Market Share by Region (2026-2031)
 Table 25. North America Tianeptine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Tianeptine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Tianeptine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Tianeptine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Tianeptine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Tianeptine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Tianeptine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Tianeptine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Tianeptine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Tianeptine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Tianeptine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Tianeptine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Tianeptine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Tianeptine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Tianeptine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tianeptine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Tianeptine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Tianeptine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Tianeptine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Tianeptine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Tianeptine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Tianeptine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Tianeptine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Tianeptine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Tianeptine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Tianeptine Sales (K Units) by Type (2020-2025)
 Table 51. Global Tianeptine Sales (K Units) by Type (2026-2031)
 Table 52. Global Tianeptine Sales Market Share by Type (2020-2025)
 Table 53. Global Tianeptine Sales Market Share by Type (2026-2031)
 Table 54. Global Tianeptine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Tianeptine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Tianeptine Revenue Market Share by Type (2020-2025)
 Table 57. Global Tianeptine Revenue Market Share by Type (2026-2031)
 Table 58. Global Tianeptine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Tianeptine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Tianeptine Sales (K Units) by Application (2020-2025)
 Table 61. Global Tianeptine Sales (K Units) by Application (2026-2031)
 Table 62. Global Tianeptine Sales Market Share by Application (2020-2025)
 Table 63. Global Tianeptine Sales Market Share by Application (2026-2031)
 Table 64. Global Tianeptine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Tianeptine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Tianeptine Revenue Market Share by Application (2020-2025)
 Table 67. Global Tianeptine Revenue Market Share by Application (2026-2031)
 Table 68. Global Tianeptine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Tianeptine Price (US$/Unit) by Application (2026-2031)
 Table 70. Servier Company Information
 Table 71. Servier Description and Business Overview
 Table 72. Servier Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Servier Tianeptine Product
 Table 74. Servier Recent Developments/Updates
 Table 75. Lupin Limited Company Information
 Table 76. Lupin Limited Description and Business Overview
 Table 77. Lupin Limited Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Lupin Limited Tianeptine Product
 Table 79. Lupin Limited Recent Developments/Updates
 Table 80. PharmaS Company Information
 Table 81. PharmaS Description and Business Overview
 Table 82. PharmaS Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. PharmaS Tianeptine Product
 Table 84. PharmaS Recent Developments/Updates
 Table 85. Antibiotice Company Information
 Table 86. Antibiotice Description and Business Overview
 Table 87. Antibiotice Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Antibiotice Tianeptine Product
 Table 89. Antibiotice Recent Developments/Updates
 Table 90. Serdia Pharmaceuticals Company Information
 Table 91. Serdia Pharmaceuticals Description and Business Overview
 Table 92. Serdia Pharmaceuticals Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Serdia Pharmaceuticals Tianeptine Product
 Table 94. Serdia Pharmaceuticals Recent Developments/Updates
 Table 95. Alvogen Company Information
 Table 96. Alvogen Description and Business Overview
 Table 97. Alvogen Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Alvogen Tianeptine Product
 Table 99. Alvogen Recent Developments/Updates
 Table 100. Bausch Health Company Information
 Table 101. Bausch Health Description and Business Overview
 Table 102. Bausch Health Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bausch Health Tianeptine Product
 Table 104. Bausch Health Recent Developments/Updates
 Table 105. Genefar B.V. Company Information
 Table 106. Genefar B.V. Description and Business Overview
 Table 107. Genefar B.V. Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Genefar B.V. Tianeptine Product
 Table 109. Genefar B.V. Recent Developments/Updates
 Table 110. Arena Pharmaceuticals Company Information
 Table 111. Arena Pharmaceuticals Description and Business Overview
 Table 112. Arena Pharmaceuticals Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Arena Pharmaceuticals Tianeptine Product
 Table 114. Arena Pharmaceuticals Recent Developments/Updates
 Table 115. Glenmark Company Information
 Table 116. Glenmark Description and Business Overview
 Table 117. Glenmark Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Glenmark Tianeptine Product
 Table 119. Glenmark Recent Developments/Updates
 Table 120. Novartis Company Information
 Table 121. Novartis Description and Business Overview
 Table 122. Novartis Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Novartis Tianeptine Product
 Table 124. Novartis Recent Developments/Updates
 Table 125. Dongwha Pharm Company Information
 Table 126. Dongwha Pharm Description and Business Overview
 Table 127. Dongwha Pharm Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Dongwha Pharm Tianeptine Product
 Table 129. Dongwha Pharm Recent Developments/Updates
 Table 130. Liconsa SA Company Information
 Table 131. Liconsa SA Description and Business Overview
 Table 132. Liconsa SA Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Liconsa SA Tianeptine Product
 Table 134. Liconsa SA Recent Developments/Updates
 Table 135. Mylan Company Information
 Table 136. Mylan Description and Business Overview
 Table 137. Mylan Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Mylan Tianeptine Product
 Table 139. Mylan Recent Developments/Updates
 Table 140. Adamed Company Information
 Table 141. Adamed Description and Business Overview
 Table 142. Adamed Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Adamed Tianeptine Product
 Table 144. Adamed Recent Developments/Updates
 Table 145. Neuraxpharm Arzneimittel Company Information
 Table 146. Neuraxpharm Arzneimittel Description and Business Overview
 Table 147. Neuraxpharm Arzneimittel Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Neuraxpharm Arzneimittel Tianeptine Product
 Table 149. Neuraxpharm Arzneimittel Recent Developments/Updates
 Table 150. Grupo Insud Company Information
 Table 151. Grupo Insud Description and Business Overview
 Table 152. Grupo Insud Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Grupo Insud Tianeptine Product
 Table 154. Grupo Insud Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Tianeptine Distributors List
 Table 158. Tianeptine Customers List
 Table 159. Tianeptine Market Trends
 Table 160. Tianeptine Market Drivers
 Table 161. Tianeptine Market Challenges
 Table 162. Tianeptine Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tianeptine
 Figure 2. Global Tianeptine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tianeptine Market Share by Type: 2024 & 2031
 Figure 4. Patent Product Picture
 Figure 5. Generic Product Picture
 Figure 6. Global Tianeptine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Tianeptine Market Share by Application: 2024 & 2031
 Figure 8. Depression and Anxiety
 Figure 9. Irritable Bowel Syndrome
 Figure 10. Global Tianeptine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Tianeptine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Tianeptine Sales (2020-2031) & (K Units)
 Figure 13. Global Tianeptine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Tianeptine Report Years Considered
 Figure 15. Tianeptine Sales Share by Manufacturers in 2024
 Figure 16. Global Tianeptine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Tianeptine Players: Market Share by Revenue in Tianeptine in 2024
 Figure 18. Tianeptine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Tianeptine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Tianeptine Sales Market Share by Country (2020-2031)
 Figure 21. North America Tianeptine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Tianeptine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Tianeptine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Tianeptine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Tianeptine Revenue Market Share by Region (2020-2031)
 Figure 33. China Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Tianeptine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Tianeptine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Tianeptine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Tianeptine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Tianeptine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Tianeptine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Tianeptine by Type (2020-2031)
 Figure 54. Global Tianeptine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Tianeptine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Tianeptine by Application (2020-2031)
 Figure 57. Global Tianeptine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Tianeptine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona